Industry

DUBLIN–(BUSINESS WIRE)–The “Global Generator Market in the Healthcare Sector 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The generator market in the healthcare sector is poised to grow by $868.87 mn during 2022-2026, accelerating at a CAGR of 2.76% during the forecast period. The report on the generator market in the healthcare sector provides a … [Read more…]

Adtralza, a biologic that targets and neutralizes the interleukin (IL)-13 cytokine1, is now approved in Europe for adolescents with moderate-to-severe atopic dermatitis.2 BALLERUP, Denmark–(BUSINESS WIRE)–NOT FOR DISTRIBUTION IN THE UK OR IRELAND LEO Pharma A/S, a global leader in medical dermatology, today announced that the European Commission (EC) has extended the marketing authorization for Adtralza® … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at The ThinkEquity Conference to be held on Wednesday, October 26 in New York City. WHO: Jennifer Ernst, Chief Executive Officer, Tivic Health WHAT: The ThinkEquity Conference … [Read more…]

Event Aims to Bolster Connection, Learning, and Encourage Participation in the Hyperinsulinism Global Registry ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading patient advocacy organization, and Congenital Hyperinsulinism International (CHI), a foremost nonprofit dedicated to improving the lives of children and adults living with congenital hyperinsulinism (HI), today announced the inaugural CHI Family Meet-Up. The one-day … [Read more…]

CONCORD, Mass.–(BUSINESS WIRE)–Tremeau Pharmaceuticals today announced that it will host a key opinion leader (KOL) webinar to discuss the unmet medical need in migraine management and the potential role for rofecoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment landscape on Tuesday, October 25, 2022, at 11:00 AM Eastern Time. A live Q&A … [Read more…]

The newly formed parent company, Surround Care, will transform care delivery and deliver transformative care ST. LOUIS–(BUSINESS WIRE)–Today Navvis and Esse Health, leaders in population health and value-based care, announced the signing of a definitive merger agreement and are forming a new healthcare company called Surround Care. The board of directors and shareholders of Navvis … [Read more…]

ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Monday, November 7, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, November 8, 2022, … [Read more…]

Wellness courses will be launched in more than 850 middle and high schools across more than 240 Texas counties to help young people address depression, anxiety and other mental health conditions. GRAND PRAIRIE, Texas–(BUSINESS WIRE)–#Amerigroup–Amerigroup, one of Texas’ largest coordinators of managed healthcare benefits, has engaged education innovator EVERFI, Inc. to launch interactive mental health … [Read more…]

− Collaboration Provides Takeda an Exclusive License to Develop and Commercialize ZED1227/TAK-227 in the United States and Other Countries Outside of Europe, Canada, Australia and China − Agreement Adds Third Investigational Therapy to Takeda’s Pipeline for the Potential Treatment of Celiac Disease OSAKA, Japan & FREIBURG, Germany & DARMSTADT, Germany–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK), Zedira and Dr. … [Read more…]

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Anil Kapur to its Board of Directors, effective October 20, 2022. Mr. Kapur is the Executive Vice President, Corporate Strategy and Chief Commercial Officer at Geron Corporation. “Anil’s deep experience in oncology and his … [Read more…]